Skip to main content
NCBI home page
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research logoLink to Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
. 2019 Dec 14;25:9547–9554. doi: 10.12659/MSM.919203

The Effects of Orientin on Proliferation and Apoptosis of T24 Human Bladder Carcinoma Cells Occurs Through the Inhibition of Nuclear Factor-kappaB and the Hedgehog Signaling Pathway

Fenghao Tian 1,A,B,C,D,E,F, Ming Tong 2,A,B,C,D,✉, Zizhi Li 2,A,B,C,✉, Weichao Huang 2,C,D,F, Yanyang Jin 2,C,D, Qingfei Cao 2,B,D, Xiaoli Zhou 1,B,F, Guangquan Tong 2,C
PMCID: PMC6929549  PMID: 31837261

Abstract

Background

Orientin is a flavone isolated from medicinal plants used in traditional Chinese medicine (TCM), which suppresses the growth of cancer cells in vitro. The effects of orientin in bladder cancer cells remains unknown. This study aimed to investigate the effect of orientin on proliferation and apoptosis of T24 human transitional cell bladder carcinoma cells in vitro in the presence of an agonist and an inhibitor of nuclear factor-kappaB (NF-κB).

Material/Methods

T24 cells were cultured and divided into four study groups: an untreated control group; a group treated with 100 μM orientin; a group treated with 100 μM orientin with NF-κB agonist, phorbol 12-myristate 13-acetate (PMA); and a group treated with 100 μM orientin and the NF-κB inhibitor, IκBα. The MTT assay was performed to assess cell viability, and flow cytometry evaluated the cell cycle. The expression of proteins in the Hedgehog signaling pathway and inflammatory cytokines were determined by Western blot and enzyme-linked immunosorbent assay (ELISA).

Results

Orientin inhibited the proliferation of T24 cells, caused cell cycle arrest, reduced cell viability, and inhibited the expression of inflammatory mediators. Treatment of T24 cells with orientin inhibited the expression of NF-κB and components of the Hedgehog signaling pathway, and the NF-κB agonist, PMA, reversed these effects.

Conclusions

Treatment of T24 human bladder carcinoma cells in vitro with orientin inhibited cell proliferation and promoted cell apoptosis by suppressing the Hedgehog signaling pathway and NF-κB.

MeSH Keywords: Apoptosis, Cell Proliferation, Urinary Bladder Neoplasms

Background

Worldwide, transitional cell carcinoma of the bladder, or bladder cancer, is a common malignancy with high morbidity, particularly in male patients. The tumor is classified histologically and superficial, without muscle invasion, and muscle-invasive [1–3]. Invasive bladder cancer has a high recurrence rate. It is important for patients who have been treated surgically with transurethral resection to attend regular follow-up examinations in the months following surgery.

The predisposing factors for bladder cancer include exposure to industrial chemicals, smoking, and increasing age [4,5]. Treatment for bladder cancer includes radiation, chemotherapy, immunotherapy, localized surgery, and radical cystectomy with urinary diversion [5–8]. Currently, research on bladder cancer has resulted in some progress in improvements in treatment [9]. However, the survival rates for patients with bladder cancer have remained unchanged for the past three decades [10]. There is a need for improvements in the prevention, diagnosis, and treatment of bladder cancer as patient survival rates need to improve. Radiation therapy and chemotherapy are associated with side effects, and the discovery for new drugs with high efficacy and low toxicity are still required.

Drug discovery requires an understanding of the underlying mechanism in cancer. Signaling pathways, including nuclear factor-kappaB (NF-κB) signaling, play an important role in bladder cancer, as tumor cell proliferation is suppressed by NF-κB in vitro and in vivo [11]. Some factors that inhibit NF-κB signaling pathways may affect tumor cell proliferation and migration, including epigallocatechin-3-gallate (EGCG), which downregulates NF-κB, and nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IkBa), which is an inhibitor of NF-κB. The topical effect of Bacillus Calmette-Guérin (BCG) in bladder cancer is enhanced by curcumin via downregulation of NF-κB [12]. Also, Hedgehog signaling is associated with the progression of bladder cancer [13]. Therefore, the NF-κB signaling pathway and the Hedgehog signaling pathway in bladder cancer were chosen for further investigation in this study.

Traditional Chinese medicine (TCM) has been used for centuries to treat human disease. Compounds extracted these medicines and herbs have been developed successfully in modern clinical practice, including paclitaxel, vinblastine, camptothecin, and artemisinin. Orientin is a flavonoid C-glycoside extracted from herbs and plants, including Passiflora edulis, millet, and bamboo leaves [14,15]. Orientin possesses a variety of biological activities in cancer, inflammation, and as an antioxidant [16–18]. Anticancer effects have been shown by flavonoid C-glycosides [19], and cell migration in human breast cancer cells was inhibited in vitro by orientin [20]. However, the effects of orientin on bladder cancer remain unknown. Therefore, the aim of this study was to investigate the effect of orientin on proliferation and apoptosis of T24 human transitional cell bladder carcinoma cells in vitro in the presence of an agonist, phorbol 12-myristate 13-acetate (PMA), and an inhibitor, IκBα, of NF-κB.

Material and Methods

Cell culture

T24 human transitional cell bladder carcinoma cells were purchased from Cobioer (Nanjing, China). Cells were cultured in a 96-well culture plate at 1×105 cells/ml in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin, at 37°C in a humidified incubator with 5% CO2.

T24 cells were cultured and divided into four study groups: an untreated control group; a group treated with 100 μM orientin; a group treated with 100 μM orientin with NF-κB agonist, phorbol 12-myristate 13-acetate (PMA) (10 ng/ml) (Sigma-Aldrich, St. Louis MO, USA); and a group treated with 100 μM orientin and the NF-κB inhibitor, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα).

MTT assay

T24 cells in the logarithmic growth phase were digested using trypsin. Then, 1 mL of complete medium was added to terminate digestion. The cell suspension was centrifuged, and the cells were collected. After cell counting, the cell density was adjusted to 3.5×104 cells/ml. Then, 100 μl cells were seeded into 96-well culture plate. After the cells became adherent, orientin at concentrations of 10, 20, 50, 100, 500, and 1000 μM were added to the culture medium, and 10 μL of MTT was added to each well of the cells at 24 h, 48 h, and 72 h. After treated with MTT, cells were cultured for another 4 h. A RNE90002 microplate reader (REAGEN LLC., Moorestown, NJ, USA) was used to measure the absorbance.

Cell cycle detection

The cells at the logarithmic growth phase were digested by 0.5 ml of 0.25% pancreatic enzymes. After centrifuging, the cells were collected and adjusted to 1×105 cells/ml, and 100 μl of cells were added to six-well plates. Orientin, at increasing doses of 10, 20, 50, 100, 500, and 1000 μM, were added to the culture medium. After 72 h, the cells were trypsinized and washed three times in PBS. The cells were suspended in PBS with 50 μg/ml of propidium iodide (PI) (Sigma-Aldrich, St. Louis MO, USA) and 100 μg/ml of RNase A. The cells were incubated at 4°C in the dark for 30 minutes. Flow cytometry was performed using the BD FACSCalibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). The results were analyzed by FlowJo version 10 software.

The expression of tumor necrosis factor α (TNFα), interleukin-1 (IL-1), and IL-6

After the cells were treated with increasing concentrations of orientin, the level of TNFα, IL-1, and IL-6 in the supernatants of the T24 cells were quantified using enzyme-linked immunosorbent assay (ELISA) kits, according to the manufacturer’s instructions. The cells in the different groups were lysed and then centrifuged to obtain the supernatants. The levels of TNFα, IL-1, and IL-6 in the supernatants of each group were determined by ELISA.

Western blot

After treatment with increasing doses of orientin, the T24 cells were lysed to obtain the total protein. The samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to polyvinylidene fluoride (PVDF) membranes and blocked with 5% dried skimmed milk powder. The membranes were incubated with the primary antibody overnight. After washing for three times, the membranes were then incubated with the secondary antibody. The Odyssey CLx Imaging System (Li-Cor Biosciences, Lincoln, NE, USA) was used to analyze the protein expression.

Statistical analysis

Data were analyzed using SPSS software version 10.0 (IBM, Chicago, IL, USA) and GraphPad Prism version 8.0 (GraphPad Software, La Jolla, CA, USA). Data were presented as the mean±standard deviation (SD). Student’s t-test determined differences between groups. P-values <0.05 represented a significant difference between groups.

Results

Orientin inhibited T24 cell proliferation and arrested the cell cycle

T24 cell viability was evaluated by the MTT assay. As shown in Figure 1A, the cells treated with orientin showed reduced viability in a dose-dependent manner. When the cells were treated with 100 μM orientin, the cell viability at 72 h was significantly lower than that at 48 h, and at 24 h. There was no significant difference in cell viability between 100 μM orientin and 1000 μM orientin. As shown in Figure 1B, as the concentration of orientin increased, there was a reduction of cells in the S phase and an accumulation of cells in G0-G1 phase. Also, the expression of the cell cycle proteins, CDK2 and cyclin E1, which have a crucial role in cell transition from the G1 phase to the S phase, were significantly reduced compared with the control group (0 μM) (Figure 2). P21 expression, which mediated cell-cycle arrest at the G1 or G2 phase, increased with increasing concentrations of orientin. These results supported that orientin had an inhibitory effect on cell proliferation by arresting the cell cycle in T24 cells in vitro.

Figure 1.

Figure 1

Open in a new tab

The effects of orientin on cell viability and the cell cycle in T24 human bladder carcinoma cells in vitro. The effect of orientin on cell viability at 24 h, 48 h, and 72 h (A) and on the cell cycle (B). * P<0.05, ** P<0.01 and *** P<0.001 vs. the control group (0 μM).

Figure 2.

Figure 2

Open in a new tab

The effects of orientin on the expression of CDK2, cyclin E1, and P21 in T24 human bladder carcinoma cells in vitro. The effect of orientin on the expression of CDK2, cyclin E1, and P21; * P<0.05, ** P<0.01 and *** P<0.001 vs. the control group (0 μM).

Orientin promoted apoptosis of T24 cells in vitro

As shown in Figure 3, apoptosis-associated proteins investigated. The expression of Bcl-2, an anti-apoptosis protein, decreased with increasing concentrations of orientin. However, the pro-apoptotic proteins, including BAX and cleaved-caspase 3, were increased with increasing concentrations of orientin. These results indicated that orientin promoted apoptosis of T24 cells in vitro in a dose-dependent manner.

Figure 3.

Figure 3

Open in a new tab

The effects of orientin on the expression of apoptosis-associated proteins, Bcl-2, BAX, and cleaved caspase-3 in T24 human bladder carcinoma cells in vitro. The effect of orientin on the expression of apoptosis-associated proteins, Bcl-2, BAX, and cleaved caspase-3. * P<0.05, ** P<0.01 and *** P<0.001 vs. the control group (0 μM).

Orientin inhibited the expression of inflammatory cytokines in T24 cells in vitro

As shown in Figure 4, the levels of TNFα, IL-1, and IL-6 increased with increasing concentrations of orientin. The proteins in the nuclear factor-kappaB (NF-κB) signaling pathway were also evaluated (Figure 5). P-P65, an activation factor of the NF-κB signaling pathway, was reduced. Following treatment with the NF-κB inhibitor, IκBα, the expression of inflammatory cytokines increased. These findings indicated the expression of inflammatory mediators in T24 cells in vitro were inhibited by orientin in a dose-dependent manner.

Figure 4.

Figure 4

Open in a new tab

The effects of orientin on the expression of TNFα, IL-1, and IL-6 in T24 human bladder carcinoma cells in vitro. The effect of orientin on level of TNFα, IL-1, and IL-6; ** P<0.01 and *** P<0.001 vs. the control group (0 μM).

Figure 5.

Figure 5

Open in a new tab

The effects of orientin on the expression of the NF-κB inhibitor, IκBα, and p-P65 in T24 human bladder carcinoma cells in vitro. The effect of orientin on the expression of the NF-κB inhibitor, IκBα, and p-P65; * P<0.05, ** P<0.01 and *** P<0.001 vs. the control group (0 μM).

Orientin inhibited the expression of Hedgehog signaling proteins way by the inhibition of NF-κB in T24 cells in vitro

As shown in Figure 6, the protein expression of shh, p-smo, smo, and Gli2 in the Hedgehog signaling pathway in the group of T24 cells treated with 100 μM of orientin were significantly downregulated compared with the control group. After treatment with 100 μM of orientin in the presence of the NF-κB agonist, phorbol 12-myristate 13-acetate (PMA), the relevant proteins in the Hedgehog signaling pathway were upregulated, compared with the group treated with orientin alone. These findings showed that the inhibitory effect of orientin on protein expression in the Hedgehog signaling pathway in T24 cells in vitro was through the inhibition of NF-κB.

Figure 6.

Figure 6

Open in a new tab

The effect of orientin on the expression of proteins in the Hedgehog signaling pathway following inhibition of nuclear NF-κB in T24 human bladder carcinoma cells in vitro. The expression of the NF-κB inhibitor, IκBα, and p-P65 in the different groups (A). The expression of proteins in the Hedgehog signaling pathway in the different groups (B); * P<0.05, ** P<0.01 and *** P<0.001 vs. the control group (0 μM).

Discussion

Worldwide, bladder cancer is the ninth most common cancer, but in China, it ranks sixth [21,22]. Bladder cancer is characterized by a high rate of recurrence and metastasis. Therefore, there is an urgent need to develop highly effective drugs to treat bladder cancer. Orientin is a flavone isolated from medicinal plants, and is used in traditional Chinese medicine (TCM). Orientin suppresses the proliferation of cancer cells and increases apoptosis in vitro, including in hepatoma cell lines [23]. A previously published study showed that orientin significantly inhibited proliferation and promoted apoptosis in esophageal carcinoma cells [24]. Orientin was reported to inhibit the proliferation and promote apoptosis of breast cancer cells [25]. The findings from the present study, of T24 human bladder carcinoma cells in vitro, showed that orientin had anti-proliferation and pro-apoptotic effects on bladder cancer cells. These effects were mediated through the inhibition of protein expression of the Hedgehog signaling pathway by suppressing nuclear factor-kappaB (NF-κB).

In this study, T24 cell proliferation was inhibited by orientin in a dose-dependent manner. Cells remained in the G0-G1 phase of the cell cycle, and the S phase was reduced, indicating the cell-cycle arrest was caused by orientin. Also, CDK2 and cyclin E1, which were transitional markers of cells from the G1 phase to the S phase, was significantly reduced by orientin. Also, P21, a mediator of cell-cycle arrest at the G1 or G2 phase, were increased by orientin. These findings supported the anti-proliferation effect of orientin in T24 cells in vitro. Apoptosis-associated proteins were increased, and the anti-apoptosis protein, Bcl-2, was reduced, which supported the effect of orientin in promoting apoptosis in T24 cells in vitro (Figure 3).

NF-κB is a transcription factor that is capable of regulating biological processes involved in malignancy, including cell proliferation, migration, and angiogenesis by inducing transcription of target genes [26–29]. Orientin has previously been shown to have an anti-proliferative effect in colorectal cancer and to inhibit NF-κB signaling [30]. In the present study, compared with the control group (0 μM), P-P65 was reduced. The use of the NF-κB inhibitor, IκBα, reversed these effects, confirming that the NF-κB signaling pathway was inhibited by orientin in T24 cells in vitro.

NF-κB is reported to promote the expression of the Shh signaling protein to activate the Hedgehog signaling pathway in pancreatic carcinoma cells [31]. NF-κB/Shh was previously shown to have a pro-proliferation effect, and a positive association between the expression of NF-κB p65 and Shh was shown in surgical resection specimens of pancreatic cancer [32]. The relationship between the NF-κB signaling pathway and the Hedgehog signaling pathway in T24 bladder cancer cells treated with orientin requires further study. However, in the present study, using a single human bladder cancer cell line, T24, orientin inhibited the expression of proteins in the Hedgehog signaling pathway by inhibiting NF-κB. This result was reversed following treatment with the NF-κB inhibitor, IκBα, (Figure 6). These preliminary in vitro findings, using a single human bladder cancer cell line, showed that orientin had an anti-proliferation effect by inhibiting the expression of Hedgehog signaling pathway proteins by suppressing the NF-κB pathway. These preliminary findings require further study using more human bladder cancer cell lines and should be supported with future in vivo studies with animal xenograft models.

Conclusions

This study aimed to investigate the effects of orientin on proliferation and apoptosis of T24 human transitional cell bladder carcinoma cells in vitro in the presence of an agonist and an inhibitor of nuclear factor-kappaB (NF-κB). Treatment of T24 human bladder carcinoma cells with orientin inhibited cell proliferation and promoted cell apoptosis by suppressing the Hedgehog signaling pathway and NF-κB. Future in vivo pharmacodynamic studies are needed to investigate the role of orientin in bladder cancer.

Footnotes

Source of support: Departmental sources

References

  • 1.Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374(9685):239–49. doi: 10.1016/S0140-6736(09)60491-8. [DOI] [PubMed] [Google Scholar]
  • 2.Chen X, Wang P, Wang S, et al. CIZ1 knockdown suppresses the proliferation of bladder cancer cells by inducing apoptosis. Gene. 2019;719:143946. doi: 10.1016/j.gene.2019.143946. [DOI] [PubMed] [Google Scholar]
  • 3.Dobruch J, Daneshmand S, Fisch M, et al. Gender and bladder cancer: A collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69(2):300–10. doi: 10.1016/j.eururo.2015.08.037. [DOI] [PubMed] [Google Scholar]
  • 4.National Institute for Health and Care Excellence (NICE) guidance (2015) Bladder cancer: Diagnosis and management of bladder cancer. BJU Int. 2017;120(6):755–65. [PubMed] [Google Scholar]
  • 5.Bhanvadia SK. Bladder cancer survivorship. Curr Urol Rep. 2018;19(12):111. doi: 10.1007/s11934-018-0860-6. [DOI] [PubMed] [Google Scholar]
  • 6.Martinez Rodriguez RH, Buisan Rueda O, Ibarz L. Bladder cancer: Present and future. Med Clin (Barc) 2017;149(10):449–55. doi: 10.1016/j.medcli.2017.06.009. [DOI] [PubMed] [Google Scholar]
  • 7.Vasekar M, Degraff D, Joshi M. Immunotherapy in bladder cancer. Curr Mol Pharmacol. 2016;9(3):242–51. doi: 10.2174/1874467208666150716120945. [DOI] [PubMed] [Google Scholar]
  • 8.Nishiyama H. Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer. Jpn J Clin Oncol. 2018;48(1):3–6. doi: 10.1093/jjco/hyx130. [DOI] [PubMed] [Google Scholar]
  • 9.Grayson M. Bladder cancer. Nature. 2017;551(7679):S33. doi: 10.1038/551S33a. [DOI] [PubMed] [Google Scholar]
  • 10.Berdik C. Unlocking bladder cancer. Nature. 2017;551:S34. doi: 10.1038/551S34a. [DOI] [PubMed] [Google Scholar]
  • 11.Cui X, Shen D, Kong C, et al. NF-kappaB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo. Sci Rep. 2017;7:40723. doi: 10.1038/srep40723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kamat AM, Tharakan ST, Sung B, Aggarwal BB. Curcumin potentiates the antitumor effects of bacillus calmette-guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors. Cancer Res. 2009;69(23):8958–66. doi: 10.1158/0008-5472.CAN-09-2045. [DOI] [PubMed] [Google Scholar]
  • 13.Mamtani R, Yang YX, Scott FI, et al. Association of itraconazole, a hedgehog inhibitor, and bladder cancer. J Urol. 2016;196(2):343–48. doi: 10.1016/j.juro.2016.01.089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Tian T, Zeng J, Zhao G, et al. Neuroprotective effects of orientin on oxygen-glucose deprivation/reperfusion-induced cell injury in primary culture of rat cortical neurons. Exp Biol Med. 2018;243(1):78–86. doi: 10.1177/1535370217737983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lam KY, Ling AP, Koh RY, et al. A review on medicinal properties of orientin. Adv Pharmacol Sci. 2016;2016 doi: 10.1155/2016/4104595. 4104595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Czemplik M, Mierziak J, Szopa J, Kulma A. Flavonoid C-glucosides derived from flax straw extracts reduce human breast cancer cell growth in vitro and induce apoptosis. Front Pharmacol. 2016;7:282. doi: 10.3389/fphar.2016.00282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Law BN, Ling AP, Koh RY, et al. Neuroprotective effects of orientin on hydrogen peroxide-induced apoptosis in SHSY5Y cells. Mol Med Rep. 2014;9(3):947–54. doi: 10.3892/mmr.2013.1878. [DOI] [PubMed] [Google Scholar]
  • 18.Thangaraj K, Natesan K, Settu K, et al. Orientin mitigates 1, 2-dimethylhydrazine induced lipid peroxidation, antioxidant and biotransforming bacterial enzyme alterations in experimental rats. J Cancer Res Ther. 2018;14(6):1379–88. doi: 10.4103/jcrt.JCRT_1363_16. [DOI] [PubMed] [Google Scholar]
  • 19.An F, Wang S, Tian Q, Zhu D. Effects of orientin and vitexin from Trollius chinensis on the growth and apoptosis of esophageal cancer EC-109 cells. Oncol Lett. 2015;10(4):2627–33. doi: 10.3892/ol.2015.3618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kim SJ, Pham TH, Bak Y, et al. Orientin inhibits invasion by suppressing MMP-9 and IL-8 expression via the PKCalpha/ERK/AP-1/STAT3-mediated signaling pathways in TPA-treated MCF-7 breast cancer cells. Phytomedicine. 2018;50:35–42. doi: 10.1016/j.phymed.2018.09.172. [DOI] [PubMed] [Google Scholar]
  • 21.Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. Cancer J Clin. 2015;65(1):5–29. doi: 10.3322/caac.21254. [DOI] [PubMed] [Google Scholar]
  • 22.Pang C, Guan Y, Li H, et al. Urologic cancer in China. Jpn J Clin Oncol. 2016;46(6):497–501. doi: 10.1093/jjco/hyw034. [DOI] [PubMed] [Google Scholar]
  • 23.Khan F, Sharma P, Prakash O, et al. Structure-activity relationship studies on holy basil (Ocimum sanctum L.) based flavonoid orientin and its analogue for cytotoxic activity in liver cancer cell line HepG2. Comb Chem High Throughput Screen. 2016;19(8):656–66. doi: 10.2174/1386207319666160709192801. [DOI] [PubMed] [Google Scholar]
  • 24.An F, Wang S, Tian Q, Zhu D. Effects of orientin and vitexin from Trollius chinensis on the growth and apoptosis of esophageal cancer EC-109 cells. Oncol Lett. 2015;10(4):2627–33. doi: 10.3892/ol.2015.3618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Czemplik M, Mierziak J, Szopa J, Kulma A. Flavonoid C-glucosides derived from flax straw extracts reduce human breast cancer cell growth in vitro and induce apoptosis. Front Pharmacol. 2016;7:282. doi: 10.3389/fphar.2016.00282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Xia Y, Shen S, Verma IM. NF-κB, an active player in human cancers. Cancer Immunol Res. 2014;2(9):823–30. doi: 10.1158/2326-6066.CIR-14-0112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441(7092):431–36. doi: 10.1038/nature04870. [DOI] [PubMed] [Google Scholar]
  • 28.Kim YR, Kim I-J, Kang TW, et al. HOXB13 downregulates intracellular zinc and increases NF-κB signaling to promote prostate cancer metastasis. Oncogene. 2014;33(37):4558–67. doi: 10.1038/onc.2013.404. [DOI] [PubMed] [Google Scholar]
  • 29.Jiang L, Lin C, Song L, et al. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop. J Clin Invest. 2012;122(1):33–47. doi: 10.1172/JCI58849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Thangaraj K, Vaiyapuri M. Orientin, a C-glycosyl dietary flavone, suppresses colonic cell proliferation and mitigates NF-κB mediated inflammatory response in 1,2-dimethylhydrazine induced colorectal carcinogenesis. Biomed Pharmacother. 2017;96:1253–66. doi: 10.1016/j.biopha.2017.11.088. [DOI] [PubMed] [Google Scholar]
  • 31.Kasperczyk H, Baumann B, Debatin K-M, Fulda S. Characterization of sonic hedgehog as a novel NF-κB target gene that promotes NF-κB-mediated apoptosis resistance and tumor growth in vivo. FASEB J. 2009;23(1):21–33. doi: 10.1096/fj.08-111096. [DOI] [PubMed] [Google Scholar]
  • 32.Nakashima H, Nakamura M, Yamaguchi H, et al. Nuclear factor-B contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res. 2006;66(14):7041–49. doi: 10.1158/0008-5472.CAN-05-4588. [DOI] [PubMed] [Google Scholar]

Articles from Medical Science Monitor : International Medical Journal of Experimental and Clinical Research are provided here courtesy of International Scientific Information, Inc.

RESOURCES